Repertoire Immune Medicines
Repertoire Immune Medicines is a Cambridge, Massachusetts biotechnology company (with a site in Schlieren, Switzerland) building immune medicines grounded in the human T cell repertoire. Its proprietary DECODE platform characterizes the immune synapse by identifying T cell receptor (TCR) and antigen (peptide-MHC) pairs together with T cell function and HLA presentation, and uses that map to rationally design treatments across oncology, autoimmune disease, and infectious disease. Backed by Flagship Pioneering and SoftBank Vision Fund, the company was surfaced as a portfolio company and added to the API Evangelist network for enrichment. It publishes no public developer API; its only public technical surface is a small research GitHub organization.
Repertoire Immune Medicines is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Immunology, and T Cell.
Repertoire Immune Medicines’ developer surface includes engineering blog, support, and 5 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API